Clinical trials
Phase 4 Breast Neoplasms trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 3 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Catholic University, Italy | 1 |
| Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte | 1 |
| Charite University, Berlin, Germany | 1 |
| Cytori Therapeutics | 1 |
| Eli Lilly and Company | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Guerbet | 1 |
| Hoffmann-La Roche | 1 |
| I.R.C.C.S. Fondazione Santa Lucia | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 12 |
| Neoplasms | 2 |
| Breast Cancer Lymphedema | 1 |
| Carcinoma | 1 |
| Carcinoma, Ductal, Breast | 1 |
| Carcinoma, Hepatocellular | 1 |
| Colorectal Neoplasms | 1 |
| Drug-Related Side Effects and Adverse Reactions | 1 |
| Lymphedema | 1 |
| Neuroendocrine Tumors | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.